Form 424B5 Traws Pharma, Inc.

Go back to Form 424B5 Traws Pharma, Inc.

Traws Pharma increases ATM offering capacity by $3.1 million

May 22, 2026 8:04 AM EDT

Traws Pharma (NASDAQ: TRAW) filed a prospectus supplement to increase its at-the-market offering capacity by $3,128,399, according to a Securities and Exchange Commission filing.

The biopharmaceutical company previously sold 3,607,270 shares under its existing ATM agreement with Citizens JMP Securities for gross proceeds of... More